Immunocore Holdings (IMCR)

Immunocore Holdings (IMCR) Financial Statements


Immunocore Holdings Financial Overview

Immunocore Holdings's market cap is currently ―. The company's EPS TTM is $-2.848; its P/E ratio is -18.65; Immunocore Holdings is scheduled to report earnings on February 29, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue£ 48.06M£ 41.20M£ 32.00M£ 22.47M£ 6.59M
Gross Profit£ 47.95M£ 41.14M£ 31.97M£ 22.23M-
EBIT£ -21.29M£ 6.77M£ -6.88M£ -16.45M£ -37.83M
EBITDA£ -19.95M£ 8.25M£ -5.24M£ -14.77M£ -36.11M
Net Income Common Stockholders£ -25.20M£ 6.23M£ -6.12M£ -16.13M£ -39.39M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 332.54M£ 347.19M£ 208.06M£ 205.85M£ 237.89M
Total Assets£ 435.52M£ 444.67M£ 295.57M£ 282.04M£ 301.77M
Total Debt£ 69.30M£ 74.08M£ 67.69M£ 64.71M£ 63.84M
Net Debt£ -263.24M£ -273.11M£ -140.37M£ -141.15M£ -174.05M
Total Liabilities£ 156.76M£ 149.85M£ 130.92M£ 118.74M£ 130.23M
Stockholders Equity£ 278.76M£ 294.82M£ 164.65M£ 163.30M£ 171.55M
Cash Flow-
Free Cash Flow£ 4.70M£ 7.70M£ -9.52M£ -30.97M£ -16.61M
Operating Cash Flow£ 6.03M£ 8.09M£ -9.18M£ -30.83M£ -16.33M
Investing Cash Flow£ 332.00K£ 203.00K£ -209.00K£ -133.00K£ -265.00K
Financing Cash Flow£ -1.19M£ 117.52M£ -538.00K£ -1.33M£ -2.06M
Currency in GBP

Immunocore Holdings Earnings and Revenue History

Immunocore Holdings Debt to Assets

Immunocore Holdings Cash Flow

Immunocore Holdings Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis